VRHI (Veri Medtech Holdings) Risk Assessment

View and export this data going back to . Start your Free Trial

What is Veri Medtech Holdings Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Veri Medtech Holdings is: No Data: Cannot be evaluated.

Competitive Comparison of Veri Medtech Holdings's Risk Assessment

For the Health Information Services subindustry, Veri Medtech Holdings's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Veri Medtech Holdings's Risk Assessment Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Veri Medtech Holdings's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Veri Medtech Holdings's Risk Assessment falls into.

Save Embed

;

Save Embed

;

Veri Medtech Holdings (OTCPK:VRHI) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Veri Medtech Holdings Risk Assessment Related Terms

Thank you for viewing the detailed overview of Veri Medtech Holdings's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Veri Medtech Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Veri Medtech Holdings Inc (OTCPK:VRHI) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

1660 International Dr, Suite 600, McClean, VA, USA, 22101

Website

https://www.verimedtech.com

Veri Medtech Holdings Inc is a healthcare technology company that offers alternative medicine, personalized diagnostics, and wellness medication on demand. The company leverages telehealth infrastructure, diagnostic intelligence, and scalable digital systems to meet the growing demand for accessible, stigma-free healthcare. Strategically positioned for growth, Veri MedTech actively explores acquisitions that complement its core capabilities and enhance patient engagement across emerging sectors of alternative medicine, longevity, and wellness science. With a integration and operational efficiency track record, the company drives accelerated revenue through the continuous generation of high-value patient databases and recurring service models.

Veri Medtech Holdings Headlines

From GuruFocus

Veri Medtech (VRHI) Retains PCAOB Auditor | VRHI Stock News

By GuruFocus News • 04-28-2025

Veri Medtech (VRHI) Relaunches DosePop.com | VRHI Stock News

By GuruFocus News • 05-05-2025

Veri Medtech (VRHI) Reaches $100 Million Revenue Milestone | VRHI Stock News

By GuruFocus News • 05-15-2025

Light Media Network Stands In Solidarity With Black Information Network

By Marketwired Marketwired • 07-14-2020